Exploring the Adoption of Implantable Brain Stimulation into Standard of Care for Central Nervous System Disorders / Search Inside This Book
68 matches found for How People Learn Brain,Mind,Experience,and School Expanded Edition. in Appendix B: Workshop Agenda
Select a page to see where your word(s) or phrase(s) are located in the OpenBook. Excerpts from the chapter provide context.
In the middle of
page 73...
... EXPLORING THE ADOPTION OF IMPLANTABLE BRAIN STIMULATION INTO STANDARD OF CARE FOR CENTRAL NERVOUS SYSTEM DISORDERS...
At the bottom of
page 73...
... Frances Jensen, University of Pennsylvania; Co-chair, Forum on Neuroscience and Nervous System Disorders...
At the bottom of
page 73...
... John Krystal, Yale University; Co-chair, Forum on Neuroscience and Nervous System Disorders...
At the bottom of
page 73...
... SESSION 1—CROSSING THE CHASM: LESSONS LEARNED ACROSS TECHNOLOGIES...
At the bottom of
page 73...
... Review the current state of knowledge regarding the clinical utilization of implantable brain stimulation across various CNS disorders and consider the future potential to improve quality of life for patients....
At the bottom of
page 73...
... Discuss the lessons learned from other technologies that have or have not “crossed the chasm” to be adopted into clinical care....
At the top of
page 74...
... Consider how these lessons learned might be applied to implantable brain stimulation....
At the top of
page 74...
... Helen Mayberg, Icahn School of Medicine at Mount Sinai; Workshop Co-chair...
At the top of
page 74...
... Share the scope of the workshop and what will not be covered....
At the top of
page 74...
... Highlight that scalability, technology, comorbidities considerations, and opportunities to overcome these barriers will be implicit throughout the workshop....
In the middle of
page 74...
... What does it mean to be a part of the standard of care?...
In the middle of
page 74...
... Provide a brief history about cardiac pacemakers and defibrillators....
In the middle of
page 74...
... What would be required for implantable brain stimulation to be adopted into the standard of care?...
In the middle of
page 74...
... Lessons Learned Across Therapeutic Areas...
At the bottom of
page 74...
... Provide an overview of the therapy and the patient need that was being addressed....
At the bottom of
page 74...
... What are some of the lessons learned that should be considered for any new implantable brain stimulation therapy?...
At the bottom of
page 74...
... Vivek Pinto, U.S. Food and Drug Administration...
At the bottom of
page 74...
... Cochlear Implants and Retinal Implants...
At the bottom of
page 74...
... Mindy Ganguly, University of Pennsylvania...
At the bottom of
page 74...
... Deep Brain Stimulation for Obsessive-Compulsive Disorder (OCD)...
In the middle of
page 75...
... SESSION 2—BENEFITS AND CHALLENGES EXPERIENCED BY INDIVIDUALS WITH LIVED EXPERIENCE...
In the middle of
page 75...
... Explore what patients need from implantable brain stimulation to define it as a successful treatment....
In the middle of
page 75...
... Discuss how adoption of this technology can impact patients and their quality of life....
In the middle of
page 75...
... Consider what challenges and barriers prevent patients from selecting this treatment or causes patients to perceive the treatment as a failure....
At the bottom of
page 75...
... SESSION 3—PRACTICAL BARRIERS I: PATIENT SELECTION AND ENGAGEMENT...
At the bottom of
page 75...
... Review the challenges associated with patient selection and engagement and with managing expectations of patients and their families....
At the bottom of
page 75...
... Consider the ethics of ensuring equitable access to all patients and demographics....
At the bottom of
page 75...
... Explore the potential opportunities or collaborations that are needed to develop informed patient selection practices and equitable access to the technology....
At the bottom of
page 75...
... Review the concerns of patients regarding the possible complications and side effects of implantable brain stimulation and potential educational campaigns to increase patient awareness of and comfort with the technology....
At the top of
page 76...
... Moderated Panel and Audience Q&A...
In the middle of
page 76...
... Joseph Candelario-Mckeown, National Hospital for Neurology and Neurosurgery...
In the middle of
page 76...
... Rachel Davis, University of Colorado Anschutz School of Medicine...
In the middle of
page 76...
... SESSION 4—PRACTICAL BARRIERS II: HEALTH PROFESSIONAL BARRIERS AND ADOPTION...
In the middle of
page 76...
... Discuss the current barriers to increase training and engagement among health professionals on implantable brain stimulation and barriers of current practices....
In the middle of
page 76...
... Explore what relationships might need to be developed across different specialties and clinical practices to facilitate referrals and continuance of care....
At the bottom of
page 76...
... David McMullen, Food and Drug Administration...
At the bottom of
page 76...
... Moderated Panel and Audience Q&A...
At the bottom of
page 76...
... Joan Miravite, Icahn School of Medicine at Mount Sinai...
At the bottom of
page 76...
... SESSION 5—PRACTICAL BARRIERS III: REIMBURSEMENT AND OTHER ECONOMIC CONSIDERATIONS...
At the bottom of
page 76...
... Consider the current economic barriers and technological limitations that prevent implantable brain stimulation from becoming scalable....
At the top of
page 77...
... Discuss what ongoing or future approaches need to be taken to improve the benefit-cost ratio and allow brain stimulation to be scalable for wider application in CNS disorders....
At the top of
page 77...
... Review the current status of reimbursement for implantable brain stimulation and discuss opportunities to increase reimbursement....
In the middle of
page 77...
... Moderated Panel and Audience Q&A...
In the middle of
page 77...
... Peter Silburn, Queensland Brain Institute (Zoom)...
In the middle of
page 77...
... Review the core themes and takeaways shared across the previous sessions....
In the middle of
page 77...
... creative approaches or collaborations needed to move the field forwards toward the end goal of adoption of implantable brain stimulation into the standard of care....
In the middle of
page 77...
... Discuss the implications of comorbidities and opportunities to develop technologies and treatments to holistically treat patients....
At the bottom of
page 77...
... Helen Mayberg, Icahn School of Medicine at Mount Sinai; Workshop Co-chair...
At the bottom of
page 77...
... Moderated Panel and Audience Q&A...
At the bottom of
page 77...
... Brandy Ellis, Neuromodulation Patient Advocate...
At the bottom of
page 77...
... Doug Kelly, Food and Drug Administration...
At the bottom of
page 78...
... Synthesis and Concluding Remarks...
At the bottom of
page 78...
... Helen Mayberg, Icahn School of Medicine at Mount Sinai; Workshop Co-chair...
A total of pages of uncorrected, machine-read text were searched in this chapter. Please note that the searchable text may be scanned, uncorrected text, and should be presumed inaccurate. Page images should be used as the authoritative version.